NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...